The healthcare and health-insurance giant posted double-digit percentage revenue growth at its Optum and UnitedHealthcare units, as the Omicron variant-driven surge in Covid cases at the start of the quarter faded.

The Dallas-based private-equity firm closed its second healthcare-focused investment fund above its $300 million target and plans to invest it in smaller businesses in the sector

The drugmaker is to cut nearly a third of its consumer healthcare products in Russia as executives across the pharmaceutical industry grapple with an ethical dilemma over their response to the war in Ukraine.

Asset manager Janus Henderson Group PLC led a $115 million investment in IntelyCare, Inc. in a deal valuing the company, whose app matches nurses with open shifts at healthcare providers, at $1.1 billion.

Nearly two years into the pandemic, doctors have few effective treatments for patients, especially early in the disease. But some therapies have been shown to work in clinical studies.

Spending is projected to have increased 4.2% in 2021, following a pandemic-fueled rise of 9.7% in 2020, report finds.

A glitch related to a health-records system run by the U.S. Department of Veterans Affairs forced the network offline in some locations, the latest hiccup in the agency’s yearslong effort to replace a system developed in the 1980s.

The owner-operator of medical-office buildings around the country is in advanced talks to combine with a smaller rival in a deal that could create a company worth more than $10 billion.

The antitrust lawsuit argues the $13 billion tie-up would lead to higher costs.

Several lower courts are considering challenges to the administration’s other Covid-19 vaccine requirements, including for federal employees and contractors.

The bill was pulled from consideration hours before a planned vote in the California Assembly after its author concluded there wasn’t enough support for it to pass.

After their failed push on elections legislation, Democrats are again turning to the economic plan, which President Biden said the party might cut into separate pieces.

The healthcare and health-insurance company’s fourth-quarter results showed little sign of a serious impact from costs tied to Omicron’s spread last month.

A surprise bid for the consumer-healthcare business jointly owned by GlaxoSmithKline and Pfizer is risky and only half of the target may really be worth owning.

The Dove soap maker laid out its biggest strategic shift in years after disclosing a $68 billion approach for GlaxoSmithKline’s consumer-health business.

Justices deliver mixed outcome on administration’s Covid-19 mandates, upending the government’s most aggressive effort to combat the pandemic via the workplace.

A robust outreach campaign and broader consumer subsidies are credited for the increase.

With less than half of India’s population fully vaccinated and infections rising rapidly, public-health experts warn that the healthcare system is again vulnerable—months after being overwhelmed by a surge of cases.

Gov. Kathy Hochul’s new requirement is awaiting approval from the state’s public-health panel, which she said she expects promptly.

Oracle’s $28.3 billion deal to buy electronic-medical-records company Cerner could address a major challenge in healthcare, that of datasets that can’t communicate with one another, analysts said.